Analysed RHYTHM PHARMACEUTICALS INC (RYTM:NASDAQ) News Sources
Here Are Friday’s Top Wall Street Analyst Research Calls: Baozun, Commerce Bancshares, Element Solutions, Evolution Petroleum, Petrobras, Rythm Pharmaceuticals, Terawulf, UMB Financial, Workday, and More
28-08-2026
247wallst.com
Rhythm Pharmaceuticals Announces New Data Presentations at the European Society for Paediatric Endocrinology Meeting
10-09-2026
yahoo.com
Rhythm Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update
04-08-2026
yahoo.com
Rhythm Pharmaceuticals Announces IMCIVREE® (setmelanotide) Receives Expanded Marketing Authorization in the United Kingdom for Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity due to Hypothalamic Injury or Impairment
11-08-2026
yahoo.com
Rhythm Pharmaceuticals Eyes AHO Growth, Global IMCIVREE Expansion and Pipeline Catalysts
17-08-2026
marketbeat.com
Eli Lilly and Novo Nordisk Can't Treat This Form of Obesity. Billionaire Stanley Druckenmiller Is Betting Rhythm Pharmaceuticals Can
23-08-2026
fool.com
Rhythm Pharmaceuticals (RYTM) Stock Looks Overvalued Despite Its 7x Five Year Run
26-08-2026
yahoo.com
What is the current price of RHYTHM PHARMACEUTICALS INC (RYTM:NASDAQ)?
The current price of RHYTHM PHARMACEUTICALS INC (RYTM:NASDAQ) is $104.71.
RHYTHM PHARMACEUTICALS INC (RYTM:NASDAQ) absolute price change since previous trading day?
The absolute price change of RHYTHM PHARMACEUTICALS INC (RYTM:NASDAQ) since the previous trading day is $2.51.
RHYTHM PHARMACEUTICALS INC (RYTM:NASDAQ) percentage price change since previous trading day?
The percentage price change of RHYTHM PHARMACEUTICALS INC (RYTM:NASDAQ) since the previous trading day is 2.456%.
What is the most recent average sentiment score for RHYTHM PHARMACEUTICALS INC (RYTM:NASDAQ)?
The most recent average sentiment score for RHYTHM PHARMACEUTICALS INC (RYTM:NASDAQ) is 71 out of 100.
What is the most recent average sentiment for RHYTHM PHARMACEUTICALS INC (RYTM:NASDAQ)?
The most recent sentiment for RHYTHM PHARMACEUTICALS INC (RYTM:NASDAQ) is .
SEC-8K** Filing Available For RHYTHM PHARMACEUTICALS INC (RYTM:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.